Negara: Australia
Bahasa: Inggris
Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)
SALMONELLA TYPHIMURIUM; THIOMERSAL; ALUMINIUM HYDROXIDE GEL
ZOETIS AUSTRALIA PTY LTD
Salmonella typhimurium (inacti
PARENTERAL LIQUID/SOLUTION/SUSPENSION
SALMONELLA TYPHIMURIUM VACCINE-MICROBIAL Active 0.0 P; THIOMERSAL MERCURY Other 0.13 mg/ml; ALUMINIUM HYDROXIDE GEL MINERAL-ALUMINIUM-BASE Other 0.0 P
1x2mL Syr
VM - Veterinary Medicine
ZOETIS AUSTRALIA
HORSE FOAL | HORSE MARE (FEMALE) | FEMALE HORSE
IMMUNOTHERAPY
SALMONELLA TYPHIMURIUM | VACCINE | EQUINE ROTAVIRUS
Poison schedule: 0; Withholding period: WHP: MEAT - NIL; Host/pest details: HORSE FOAL: [SALMONELLA TYPHIMURIUM, VACCINE]; HORSE MARE (FEMALE): [SALMONELLA TYPHIMURIUM, VACCINE]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE FOAL: [SALMONELLA TYPHIMURIUM, VACCINE]; HORSE MARE (FEMALE): [SALMONELLA TYPHIMURIUM, VACCINE]; For the immunisation of mares and foals as an aid in the control of diseases caused by Salmonella typhimurium.Vaccination is not recommended within 4 weeks of birth. Do not vaccinate stallions and horses in training. See also SIDE EFFECTS and PRECAUTIONS on leaflet.
Registered
2023-07-01
APPENDIX 2 AUSTRALIAN GOVERNMENT AUSTRALIAN PESTICIDES AND VETERINARY MEDICINES AUTHORITY TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS} (VETERINARY PRODUCTS) Select appropriate: C New Product (include all applicable RLPs) OR 0 Variation (highlight instructions that are being varied). Approval no. of label being varied: 38995/57147. Signal heading: Product name: Active constituenUs: Statement of claims: Net contents: Directions for Use Heading: Restraints: CONTRAINDICATIONS: PRECAUTIONS: Side effects: Dosage & ADMINISTRATION: FOR ANIMAL TREATMENT ONLY KEEP OUT OF REACH OF CHILDREN EQUIVAC® EST EQUINE SA/MONEL/A TYPHIMURIUM VACCINE Equivac EST contains inactivated Salmonella typhimurium (2.5 x 10 9 cells/ml) adjuvanted with aluminium hydroxide gel. Thiomersal (0.13 mg/ml) added as a preservative. Each batch is fully tested before issue and complies with accepted standards of potency, sterility and lack of non-specific toxicity. For the immunisation of mares and foals as an aid in the control of diseases caused by Salmonella typhimurium. 2 ml dose syringe READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT + DIRECTIONS FOR USE Contents must be left in outer package until immediately before use SHAKE WELL BEFORE USE For Intramuscular Use Only RLP r~ -n- N/A Do not vaccinate stallions and horses in training. Vaccination is not recommended within 4 weeks of expected birth. In some animals, the injection of vaccine can cause a painful swelling which appears within 1 to 2 days and can persist for up to 2 weeks. For this reason injection into the rump is advised. Slight lameness may occur for a day or so in horses which react severely to the vaccine but this will not affect feeding or general well-being. Mildly affected animals may favour the leg on the vaccinated side. NOTE: If the vaccine is injected in the neck, the horse may have difficulty with feeding, particularly off the ground, for a few days. DOSAGE FOR FOALS AND MARES: 2 ml dose (full contents of one syringe) by deep intramuscular injection PREFERABLY INTO TH Baca dokumen lengkapnya
Product Name: Equivac EST Equine Salmonella Typhimurium Vaccine Page: 1 of 5 This revision issued: November, 2012 SAFETY DATA SHEET Issued by: Pfizer Animal Health Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER Pfizer Animal Health Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: 1800 814 883 Fax: (02) 9850 3399 __________________________________________________________ PFIZER ANIMAL HEALTH AUSTRALIA PTY LTD ABN 94 156 476 425 CHEMICAL NATURE: Water solution of formalin-inactivated cells of _Salmonella typhimurium_. TRADE NAME: EQUIVAC EST EQUINE SALMONELLA TYPHIMURIUM VACCINE OTHER NAMES: Equine Salmonella Typhimurium Vaccine APVMA CODE: 38995 PRODUCT USE: Vaccination as an aid in control of disease caused by _Salmonella Typhimurium_ in horses. CREATION DATE: JULY, 2012 THIS VERSION ISSUED: NOVEMBER, 2012 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSMP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Fluid bacterial vaccine in a vial. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S NOTE: DIFFERENT HAZARD ASSESSMENT CRITERIA OF SWA AND TGA MAY RESULT IN SEEMING INCONSISTENCIES BETWEEN MSDS AND LABEL. EFFECTS DESCRIBED IN THIS MSDS RELATE TO Baca dokumen lengkapnya